All the mice of NT group had to be euthanized due to large tumor volume on day 18, NKG2D-CAR T cells produced remarkable antitumor ability in vivo compared with NT group, and the survival rate of tumor-bearing mice was more than 80% (Figure 5b). Here, KLRK1 is linked to neoplasm.